BioCatalystWatch
VCELWorkspace / VCEL / OverviewCompany library
Vericel Corp logo

Vericel Corp

Vericel Corp (VCEL)

Website

Featured programme · ixmyelocel-T

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

MACI

Cell therapy

Approved

PreINDP1P2P3FilingApproved
MACI

Cell therapy

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

MACI

Cell therapy

Approved

PreINDP1P2P3FilingApproved
MACI

Cell therapy

PreINDP1P2P3FilingApproved

Other pipelines

MACI

Cell therapy

PreINDP1P2P3FilingApproved
ixmyelocel-T

Cell therapy

PreINDP1P2P3FilingApproved

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

History / paused

ixmyelocel-T

Cell therapy

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VCEL PR & News

PR & News

VCEL SEC archive